Komipharm is trading at 17,750 KRW as of 10:31 AM on the 15th, unchanged from the previous day. This represents an 11.47% decline compared to May 18. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 9,516 shares. Over the past five days, individual investors have been net buyers of 126,088 shares, while foreigners and institutions have been net sellers of 75,068 shares and 48,920 shares, respectively.

On June 8, Komipharm was a market issue due to the news of the Ministry of Food and Drug Safety rejecting the clinical trial of its COVID-19 treatment, causing a weak stock performance.



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing